ArticleInternational neurourology journal2026
Efficacy and Safety of Endourological Surgery for Managing Overactive Bladder Symptoms in Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis.
Article in International neurourology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- HoLEP for large and mega glands: real-world outcomes and evidence of size-enhanced efficiency.International urology and nephrology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo systematically review the outcomes of endoscopic surgery in men with benign prostatic hyperplasia (BPH) associated with preoperative overactive bladder (OAB) symptoms.
methodsLiterature search was conducted on 12th May 2025 including PubMed, MEDLINE, Embase, and Scopus database. Complication rates were assessed using the Cochran-Mantel-Haenszel Method with the random effect model and reported as odds ratio, 95% confidence interval (CI), and P-values. Analyses were 2-tailed and the significance was set at P<0.05. Continuous variables were pooled using the inverse variance of the mean difference with a random effect, 95% CI, and P-values.
resultsThirteen studies were included. Overall, there were 1,436 patients, with 672 in the OAB group and 820 patients in the No OAB group. At 6 months postoperatively, the storage symptoms - International Prostate Symptom Score (IPSS) favored the OAB group (mean difference [MD], 1.06; 95% CI, 0.18-1.95; P=0.02); however, changes at 3 and 6 months demonstrated no significant differences. Total-IPSS remained comparable between groups at 3 and 6 months, whereas at 12 months, the No OAB group exhibited significantly better outcomes (MD, 3.66; 95% CI, 1.87-5.45; P<0.0001). The quality-of-life (QoL) index shows no significant difference at 3 months, though HoLEP (holmium laser enucleation of the prostate) favored the OAB group at 6 months (MD, -0.36; 95% CI, -0.62 to -0.10; P=0.006), while overall changes beyond this period favored the No OAB group (MD, -0.61; 95% CI, -1.18 to -0.05; P=0.03). Urge urinary incontinence and the need for postoperative anticholinergic therapy did not differ significantly between groups at any time.
conclusionThis meta-analysis reveals that BPH patients with preoperative OAB experienced persistently higher postoperative storage symptoms despite comparable overall symptom improvement, with a more pronounced QoL enhancement over time. These findings emphasize the need for comprehensive preoperative assessment to guide patient counseling, refine surgical expectations, and improve postoperative management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.